CS29991A2 - Tricyclo-cyclic amines, method of their preparation and pharmaceutical preparations that them contain - Google Patents

Tricyclo-cyclic amines, method of their preparation and pharmaceutical preparations that them contain Download PDF

Info

Publication number
CS29991A2
CS29991A2 CS91299A CS29991A CS29991A2 CS 29991 A2 CS29991 A2 CS 29991A2 CS 91299 A CS91299 A CS 91299A CS 29991 A CS29991 A CS 29991A CS 29991 A2 CS29991 A2 CS 29991A2
Authority
CS
Czechoslovakia
Prior art keywords
group
carbon
piperidinyl
atom
ring
Prior art date
Application number
CS91299A
Other languages
Czech (cs)
English (en)
Inventor
Yuhpyng L Chen
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of CS29991A2 publication Critical patent/CS29991A2/cs

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CS91299A 1990-02-08 1991-02-07 Tricyclo-cyclic amines, method of their preparation and pharmaceutical preparations that them contain CS29991A2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US47692890A 1990-02-08 1990-02-08

Publications (1)

Publication Number Publication Date
CS29991A2 true CS29991A2 (en) 1991-09-15

Family

ID=23893824

Family Applications (1)

Application Number Title Priority Date Filing Date
CS91299A CS29991A2 (en) 1990-02-08 1991-02-07 Tricyclo-cyclic amines, method of their preparation and pharmaceutical preparations that them contain

Country Status (21)

Country Link
EP (1) EP0441517A3 (xx)
JP (1) JPH07119214B2 (xx)
KR (1) KR950013562B1 (xx)
CN (1) CN1054600A (xx)
AU (1) AU631723B2 (xx)
BR (1) BR9100519A (xx)
CA (1) CA2035805C (xx)
CS (1) CS29991A2 (xx)
DE (1) DE9101348U1 (xx)
EG (1) EG19644A (xx)
FI (1) FI910592A (xx)
HU (1) HUT70051A (xx)
IE (1) IE910402A1 (xx)
IL (1) IL97140A (xx)
NO (1) NO177534C (xx)
NZ (1) NZ237040A (xx)
PL (2) PL167078B1 (xx)
PT (1) PT96681A (xx)
TW (1) TW197442B (xx)
YU (1) YU21391A (xx)
ZA (1) ZA91916B (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2807577B2 (ja) * 1990-06-15 1998-10-08 エーザイ株式会社 環状アミド誘導体
EP0475908A1 (de) * 1990-09-14 1992-03-18 Ciba-Geigy Ag Chromogene Lactamverbindungen und ihre Herstellung und Verwendung
TW263504B (xx) 1991-10-03 1995-11-21 Pfizer
TW248556B (xx) * 1993-01-18 1995-06-01 Takeda Pharm Industry Co
US5620973A (en) * 1993-11-30 1997-04-15 Takeda Chemical Industries, Ltd. Tetracyclic condensed heterocyclic compounds and their use
CN1572299A (zh) 1998-09-30 2005-02-02 武田药品工业株式会社 改善膀胱排泄能力的药物
ATE479686T1 (de) 2002-10-30 2010-09-15 Merck Frosst Canada Ltd Pyridopyrrolizin- und pyridoindolizinderivate
US7662831B2 (en) 2006-07-27 2010-02-16 Wyeth Llc Tetracyclic indoles as potassium channel modulators
US7601856B2 (en) 2006-07-27 2009-10-13 Wyeth Benzofurans as potassium ion channel modulators
WO2012038966A1 (en) 2010-09-22 2012-03-29 Tyche Industries Ltd. Process for the preparation of donepezil intermediate
JOP20200030A1 (ar) * 2017-09-07 2020-02-12 Eisai R&D Man Co Ltd مركب خماسي الحلقة
EA202191966A1 (ru) 2019-03-05 2021-12-08 Эйсай Ар Энд Ди Менеджмент Ко., Лтд. Пентациклическое гетероциклическое соединение
AU2020233452A1 (en) 2019-03-05 2021-09-02 Eisai R&D Management Co., Ltd. Salt of pentacyclic compound and crystals thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3910947A (en) * 1969-07-24 1975-10-07 Sandoz Ag Preparation of imidazo{8 2,1-a{9 isoindoles
IT1199076B (it) * 1984-03-01 1988-12-30 Consiglio Nazionale Ricerche Derivati della fisostigmina con proprieta'di inibizione della aceticolinesterasi e relativo procedimento di produzione
US4563469A (en) * 1984-07-20 1986-01-07 Warner-Lambert Company Derivatives of N-[2-(tetrahydro-3,5-dioxo-1H-pyrrolizin-7a(5H)-yl)ethyl]amine as cognition activators
EP0187619A3 (de) * 1985-01-03 1987-08-26 Ciba-Geigy Ag 1,3-disubstituierte Tetrahydropyridine
US4791107A (en) * 1986-07-16 1988-12-13 Hoechst-Roussel Pharmaceuticals, Inc. Memory enhancing and analgesic 1,2,3,3A,8,8A-hexahydro-3A,8 (and) 1,3A,8)-di(and tri)methylpyrrolo(2,3-B)indoles, compositions and use
US4778812A (en) * 1987-06-12 1988-10-18 American Home Products Corporation 2,3-dihydro-9-methyl-1H-pyrrolo[1,2-a]indol-1-amines and derivatives thereof
EP0351283A1 (fr) * 1988-07-12 1990-01-17 Synthelabo Dérivés de [(pipéridinyl-4) méthyl]-2 dihydro-2,3 1H-isoindole et tétrahydro-2,3,4,5 1H-benzazépines, leur préparation et leur application en thérapeutique

Also Published As

Publication number Publication date
IL97140A (en) 1995-07-31
KR910015580A (ko) 1991-09-30
HUT70051A (en) 1995-09-28
PL167078B1 (pl) 1995-07-31
YU21391A (sh) 1994-01-20
HU910406D0 (en) 1991-08-28
FI910592A0 (fi) 1991-02-07
EP0441517A3 (en) 1992-08-19
PT96681A (pt) 1991-10-31
CN1054600A (zh) 1991-09-18
EP0441517A2 (en) 1991-08-14
NO177534C (no) 1995-10-04
IE910402A1 (en) 1991-08-14
BR9100519A (pt) 1991-10-29
NZ237040A (en) 1993-10-26
NO910473D0 (no) 1991-02-07
NO177534B (no) 1995-06-26
TW197442B (xx) 1993-01-01
PL288977A1 (en) 1992-01-13
JPH04234845A (ja) 1992-08-24
CA2035805C (en) 1995-06-27
PL166757B1 (pl) 1995-06-30
AU7087991A (en) 1991-08-29
JPH07119214B2 (ja) 1995-12-20
AU631723B2 (en) 1992-12-03
IL97140A0 (en) 1992-05-25
FI910592A (fi) 1991-08-09
EG19644A (en) 1995-08-30
ZA91916B (en) 1992-09-30
KR950013562B1 (ko) 1995-11-09
DE9101348U1 (de) 1991-06-06
NO910473L (no) 1991-08-09

Similar Documents

Publication Publication Date Title
DE60013803T2 (de) Tetracyclische azepinoindol verbindungen als 5-ht rezeptor liganden
EP1192165B1 (en) Substituted heterocycle fused gamma-carbolines
US5308854A (en) Inhibitors of HIV reverse transcriptase
US7592454B2 (en) Substituted hexahydro-pyridoindole derivatives as serotonin receptor agonists and antagonists
KR102511441B1 (ko) 트리시클릭 Rho 키나제 억제제
RU2100357C1 (ru) Гетероариламины или их фармацевтически приемлемые соли и фармацевтическая композиция на их основе
US7691893B2 (en) Chemical compounds
WO1997047601A1 (fr) Composes heterocycliques fusionnes et leurs utilisations medicinales
AU2003263413A1 (en) Heterocyclic substituted piperazines for the treatment of schizophrenia
SK7032003A3 (en) Substituted pyrroloquinolines and pyridoquinolines as serotonin agonists and antagonists
CS29991A2 (en) Tricyclo-cyclic amines, method of their preparation and pharmaceutical preparations that them contain
CA2724219C (en) 5-[5-[2-(3,5-bis(trifluoromethyl)phenyl)-2-methylpropanoylmethylamino]-4-(4-fluoro-2-methylphenyl)]-2-pyridinyl-2-alkyl-prolinamide as nk1 receptor antagonists
CA2316388C (en) Tetrahydrobenzindole derivative
CA2110337A1 (en) O-aryl ethers of morphinans
KR100485020B1 (ko) 옥타하이드로-2H-피리도[1,2-a]피라진 화합물, 이들의 제조방법 및 이들을 함유하는 약제학적 조성물
EP2061461B1 (en) 3-azabicyclo[4.1.0]heptane derivatives for the treatment of depression
EP0556813B1 (en) Amphoteric tricyclic compounds as antihistaminic and antiallergic agents
US20130150376A1 (en) Novel Sultam Compounds
EP0670313A1 (en) Spiro compounds, their production and use
US5428043A (en) Tricyclic-cyclic amines as novel cholinesterase inhibitors
KR20070097419A (ko) 아릴피페라진 유도체 및 5-에취티1에이 수용체 리간드로서그 사용
US20100311734A1 (en) Spiro Compounds Useful as Antagonists of the H1 Receptor
MXPA99003911A (en) Bicyclical derivatives substituted to treat disorders of the central nervous system
JPH07291935A (ja) スピロ化合物、その製造法および剤